Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 25

Trial Status

Completed5

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT00944749Phase 2Completed
Horse ATG/CsA in Aplastic Anemia Patients Unresponsive to or With a Suboptimal Response to Rabbit ATG/CsA Treatment
Anemia, AplasticAnemia, Hypoplastic
PrincipalinvestigatorStart date: 2009-08-31
NCT00065260Phase 2Completed
Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic Anemia
Aplastic Anemia
PrincipalinvestigatorStart date: 2003-11-06
NCT00260689Phase 2Completed
Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia
ImmunosuppresionNeutropeniaPancytopenia+1 more
Principalinvestigator
NCT01187017Phase 1/2Completed
A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia
Aplastic AnemiaNeutropeniaPancytopenia+1 more
Principalinvestigator
NCT01193283Phase 1/2Completed
Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia
Aplastic AnemiaNeutropeniaPancytopenia+1 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Neal S Young, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
15 trials

Shared therapeutic areas:

Severe Aplastic AnemiaAnemia, AplasticPancytopenia+1 more

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score17%

Jeffrey McCullough, MD

University of Minnesota

Related
5 trials

Shared therapeutic areas:

ThrombocytopeniaNeutropenia

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score9%

Cassandra Josephson, MD

Emory University

Related
4 trials

Shared therapeutic areas:

NeutropeniaThrombocytopenia

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score9%

Xianyun Wang, Doctor

The First Hospital of Hebei Medical University

Related
4 trials

Shared therapeutic areas:

Anemia, Aplastic
Similarity Score4%

Erez Nadir, MD

Hillel Yaffe Medical Center

Related
11 trials

Shared therapeutic areas:

Neutropenia
Similarity Score4%

Thomas Raife, MD

University of Iowa

Related
3 trials

Shared therapeutic areas:

Thrombocytopenia

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score4%

Mitchell S Cairo, MD

New York Medical College

Related
13 trials

Shared therapeutic areas:

Severe Aplastic Anemia
Similarity Score4%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Anemia, Aplastic

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score4%

James George, MD

University of Oklahoma

Related
3 trials

Shared therapeutic areas:

Neutropenia

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score4%

Joseph Kiss, MD

University of Pittsburgh

Related
3 trials

Shared therapeutic areas:

Thrombocytopenia

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT00944749Phase 2PrincipalInvestigator

Horse ATG/CsA in Aplastic Anemia Patients Unresponsive to or With a Suboptimal Response to Rabbit ATG/CsA Treatment

Anemia, AplasticAnemia, Hypoplastic
Completed
NCT00065260Phase 2PrincipalInvestigator

Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic Anemia

Aplastic Anemia
Completed
NCT00260689Phase 2PrincipalInvestigator

Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia

ImmunosuppresionNeutropeniaPancytopenia+1 more
Completed
NCT01187017Phase 1/2PrincipalInvestigator

A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia

Aplastic AnemiaNeutropeniaPancytopenia+1 more
Completed
NCT01193283Phase 1/2PrincipalInvestigator

Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia

Aplastic AnemiaNeutropeniaPancytopenia+1 more
Completed

All 5 trials loaded